The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980-2002

Ophthalmology

Volumn 115, Issue 1, 2008, Pages 169-173

  Kitzmann, Anna S ^a   Pulido, Jose S ^a   Diehl, Nancy N ^a   Hodge, David O ^a   Burke, James P ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CENTRAL SEROUS RETINOPATHY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

ADULT; AGE DISTRIBUTION; BLOOD; CASE-CONTROL STUDIES; CHOROID DISEASES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; RECURRENCE; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 37349087448     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.02.032     Document Type: Article

References (19)

1. Gass J.D.M. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 3rd ed. (1987), Mosby, St. Louis 46-59
2. Yannuzzi L.A. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 84 (1986) 799-845
3. Klein M.L., van Buskirk E.M., Friedman E., et al. Experience with nontreatment of central serous chorioretinopathy. Arch Ophthalmol 91 (1974) 247-250
4. Tittl M.K., Spaide R.F., Wong D., et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128 (1999) 63-68
5. Haimovici R., Koh S., Gagnon D.R., et al. Risk factors for central serous chorioretinopathy. A case-control study. Ophthalmology 111 (2004) 244-249
6. Mansuetta C.C., Mason III J.O., Swanner J., et al. An association between central serous chorioretinopathy and gastroesophageal reflux disease. Am J Ophthalmol 137 (2004) 1096-1100
7. Karadimas P., and Bouzas E.A. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol 242 (2004) 800-802
8. Gass J.D., Slamovits T.L., Fuller D.G., et al. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 110 (1992) 1717-1722
9. Sunness J.S., Haller J.A., and Fine S.L. Central serous chorioretinopathy and pregnancy. Arch Ophthalmol 111 (1993) 360-364
10. Brancato R., Scialdone A., Pece A., et al. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol 225 (1987) 166-168
11. Castro-Correia J., Coutinho M.F., Rosas V., and Maia J. Long-term follow-up of central serous chorioretinopathy in 150 patients. Doc Ophthalmol 81 (1992) 379-386
12. Ficker L., Vafidis G., While A., and Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 72 (1988) 829-834
13. Gilbert C.M., Owens S.L., Smith P.D., and Fine S.L. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 68 (1984) 815-820
14. Melton III L.J. History of the Rochester Epidemiology Project. Mayo Clin Proc 71 (1996) 266-274
15. Spaide R.F., Campeas L., Haas A., et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 103 (1996) 2070-2079 discussion 2079-80
16. Spaide R.F., Hall L., Haas A., et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16 (1996) 203-213
17. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
18. Bergstralh EJ, Offord KP, Chu CP, et al. Calculating Incidence, Prevalence and Mortality Rates for Olmsted County, Minnesota: An Update. Rochester, MN: Mayo Clinic; 1992. Technical Report 49.
19. Carvalho-Recchia C.A., Yannuzzi L.A., Negrao S., et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 109 (2002) 1834-1837